• 457 Citations
  • 13 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research interests

Jonathan G. Stine, MD, MSc, FACP, is an Assistant Professor of Medicine and funded physician scientist in the Division of Gastroenterology and Hepatology at Penn State Health Milton S. Hershey Medical Center. Dr. Stine earned his undergraduate degree from Penn State.

Dr. Stine's clinical and research areas of expertise include NAFLD, coagulation disorders in chronic liver disease, drug-induced liver injury (DILI) and liver transplantation. The majority of his early work focused on DILI in both the population at large, as well as in special populations, including the elderly and patients with underlying chronic liver disease including cirrhosis. His more recent work has focused on liver transplantation coagulation disorders and outcomes-based research in which the link between pre- and post-transplantation vascular events was demonstrated. Additionally, Dr. Stine and his research group found that despite broader organ-sharing policies, geographic disparities persist and regional access to liver transplantation remains highly variable and inequitable.

Dr. Stine is the principal investigator on the NASHFit Trial and is continuing forward his work on the hypercoagulable environment in NASH patients, where he previously demonstrated that NASH increases one's risk of venous thromboembolic disease.

Dr. Stine serves as the Director of Research, Penn State Liver Center.

Professional information

Fellow of the American College of Physicians (FACP), 2016

Education/Academic qualification

Transplant Hepatology Fellowship, NIH/NIDDK T32 training grant, University of Virginia

… → 2017

Gastroenterology and Hepatology Fellowship, NIH/NIDDK T32 training grant, University of Virginia

… → 2016

Masters of Science in Clinical Research, University of Virginia

… → 2015

Internal Medicine, Chief Medical Residency, Georgetown University Hospital

… → 2013

Internal Medicine Residency, Georgetown University Hospital

… → 2012

MD, Georgetown University

… → 2009

Nutritional Sciences, BS, The Pennsylvania State University

… → 2005

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 6 Similar Profiles
Chemical and Drug Induced Liver Injury Medicine & Life Sciences
Portal Vein Medicine & Life Sciences
Fibrosis Medicine & Life Sciences
Thrombosis Medicine & Life Sciences
Liver Medicine & Life Sciences
Liver Transplantation Medicine & Life Sciences
Chronic Hepatitis C Medicine & Life Sciences
Antiviral Agents Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2018

1 Citations

Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference

Intagliata, N. M., Argo, C. K., Stine, J. G., Lisman, T., Caldwell, S. H. & Violi, F., Aug 1 2018, In : Thrombosis and Haemostasis. 118, 8, p. 1491-1506 16 p.

Research output: Contribution to journalArticle

Liver Diseases
Liver Transplantation
Coronary Artery Disease
6 Citations

Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study

Stine, J., Wang, J., Shah, P. M., Argo, C. K., Intagliata, N., Uflacker, A., Caldwell, S. H. & Northup, P. G., Jan 1 2018, In : Liver International. 38, 1, p. 94-101 8 p.

Research output: Contribution to journalArticle

Portal Vein
Case-Control Studies
End Stage Liver Disease

Geographic variation in liver transplantation persists despite implementation of Share35

Stine, J., Northup, P. G., Stukenborg, G. J., Cornella, S. L., Maluf, D. G., Pelletier, S. J. & Argo, C. K., Mar 1 2018, In : Hepatology Research. 48, 4, p. 225-232 8 p.

Research output: Contribution to journalArticle

Liver Transplantation
Waiting Lists
Organ Transplantation

Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis original-contribution

Stine, J., Niccum, B. A., Zimmet, A. N., Intagliata, N., Caldwell, S. H., Argo, C. K. & Northup, P. G., Mar 1 2018, In : Clinical and Translational Gastroenterology. 9, 3, 140.

Research output: Contribution to journalArticle

Venous Thromboembolism
Fatty Liver
End Stage Liver Disease
Portal Vein